T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy

被引:111
|
作者
Franco, JM
Rubio, A
Martínez-Moya, M
Leal, M
Merchante, E
Sánchez-Quijano, A
Lissen, E
机构
[1] Hosp U Virgen Rocio, Dept Med Interna, Viral Hepatitis & AIDS Study Grp, Seville 41013, Spain
[2] Hosp U Virgen Rocio, Dept Radiol, Seville 41013, Spain
关键词
D O I
10.1182/blood.V99.10.3702
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The origin of T cells after highly active antiretroviral therapy (HAART) in patients infected with human immunodeficiency virus 1 (HIV-1) is now under discussion. The possibility of renewed lymphopoiesis in aged thymuses is still controversial. In this work we combine the analysis of naive T cells, T-cell receptor excision circles (TRECs), and computed tomography scanning of thymic tissue to further assess whether the thymus is involved in immune reconstitution. Fifteen antiretroviral-naive HIV-1-infected patients were evaluated during 48 weeks of HAART. At baseline, significant correlation was present among age and both thymic volume and TRECs, and between naive T cells and TRECs. After starting HAART, there was a significant increase at week 12 in naive CD4(+) and CD8(+) T cells, TRECs, and thymic volume. The initial net Increases in naive T cells and TREC counts were significantly correlated. Changes In thymic volume and TRECs were also indirectly related; splitting the population Into 2 groups of high and low baseline levels, only the group with low TREC levels had significant increases In both TRECs and thymic volume. Thus, the Increase in thymic volume might be functional, In response to depleted TREC levels. Taken together, our data strongly suggest a thymic role In Immune reconstitution, at least in patients with depleted baseline TREC levels. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:3702 / 3706
页数:5
相关论文
共 50 条
  • [41] Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapy
    van Leth, F
    Wit, FWNM
    Reiss, P
    Schattenkerk, JKME
    van der Ende, ME
    Schneider, MME
    Mulder, JW
    Frissen, PHJ
    deWolf, F
    Lange, JMA
    [J]. HIV MEDICINE, 2004, 5 (02) : 74 - 81
  • [42] Healthy HIV-1-Infected Individuals on Highly Active Antiretroviral Therapy Harbor HIV-1 in Their Alveolar Macrophages
    Cribbs, Sushma K.
    Lennox, Jeffrey
    Caliendo, Angela M.
    Brown, Lou Ann
    Guidot, David M.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2015, 31 (01) : 64 - 70
  • [43] Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4+ T cells in HIV-infected adults after highly active antiretroviral therapy (HAART)
    Ruiz-Mateos, E
    Rubio, A
    Vallejo, A
    De la Rosa, R
    Sanchez-Quijano, A
    Lissen, E
    Leal, M
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 136 (03): : 501 - 506
  • [44] Negative influence of age on CD4+ cell recovery after highly active antiretroviral therapy in naive HIV-1-infected patients with severe immunodeficiency
    Micheloud, Dariela
    Berenguer, Juan
    Bellon, Jose M. A.
    Miralles, Pilar
    Cosin, Jaime
    de Quiros, Juan Carlos Lopez-Bernaldo
    Conde, Matilde Sanchez
    Munoz-Fernandez, M. Angeles
    Resino, Salvador
    [J]. JOURNAL OF INFECTION, 2008, 56 (02) : 130 - 136
  • [45] Decreased apoptosis of bone marrow progenitor cells in HIV-1-infected patients during highly active antiretroviral therapy
    Isgrò, A
    Mezzaroma, I
    Aiuti, A
    Fantauzzi, A
    Pinti, M
    Cossarizza, A
    Aiuti, F
    [J]. AIDS, 2004, 18 (09) : 1335 - 1337
  • [46] Cerebrovascular Ischemic Events in HIV-1-Infected Patients Receiving Highly Active Antiretroviral Therapy: Incidence and Risk Factors
    Corral, Inigo
    Quereda, Carmen
    Moreno, Ana
    Perez-Elias, Maria-Jesus
    Dronda, Fernando
    Casado, Jose-Luis
    Muriel, Alfonso
    Masjuan, Jaime
    Alonso-de-Lecinana, Maria
    Moreno, Santiago
    [J]. CEREBROVASCULAR DISEASES, 2009, 27 (06) : 559 - 563
  • [47] Evolution of Hematological Parameters in HIV-1-Infected Patients With and Without Thalassemia Carriages During Highly Active Antiretroviral Therapy
    Pornprasert, Sakorn
    Sonboon, Pakhaporn
    Kiatwattanacharoen, Suchart
    Klinbuayaem, Virat
    Leenasirimakul, Prattana
    Promping, Channat
    Inta, Prasit
    Ajhan, Siraporn
    Leechanachai, Pranee
    [J]. HIV CLINICAL TRIALS, 2009, 10 (02): : 88 - 93
  • [48] Role of highly active antiretroviral therapy in human papillomavirus-induced genital dysplasia in HIV-1-infected patients
    Orlando, G
    Fasolo, MM
    Schiavini, M
    Signori, R
    Cargnel, A
    [J]. AIDS, 1999, 13 (03) : 424 - 425
  • [49] Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy
    Koppel, K
    Bratt, G
    Schulman, S
    Bylund, H
    Sandström, E
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (05) : 441 - 449
  • [50] Predictors of virologic failure in HIV-1-infected patients starting highly active antiretroviral therapy in Porto Alegre, Brazil
    Tuboi, SH
    Harrison, LH
    Sprinz, E
    Albernaz, RKM
    Schechter, M
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (03) : 324 - 328